As both our data and a previous report [11] showed no difference in BRG1 expression within the groups of normal liver, non-fibrosis, chronic hepatitis and fibrosis/cirrhosis, this confirms that alterations of BRG1 may occur at a later time point of the cirrhosis-carcinoma sequence. The gene discussed is SMARCA4; the disease is carcinoma.